Deal Spotlight
Nov 8, 2026November 8, 2026
Anaheim Bio raises EUR40M with Dora Ventures, Frazier Life Sciences, Novartis, RTW, RV Invest, Thuja Capital
EUR40M
round size
series-a
stage
Anaheim Bio closed the round on November 1, 2026, with participation from Dora Ventures, Frazier Life Sciences, Novartis, RTW, RV Invest, and Thuja Capital. The company had no prior rounds recorded.
Based in the Netherlands, the company operates in Healthcare & Life Sciences at the Series A stage. It focuses on unlocking the power of small molecules to transform disease and improve patients. Founders include Ilan Ganot and Rick Dekker among others.
Brouky tracks 74 deals in Healthcare & Life Sciences in the Netherlands over the past 12 months, with a median round size of €10.1M.
Related insights
- Deal SpotlightT-Unit raises EUR50M Series C+ backed by Lakestar
- Deal SpotlightPhoton Bridge raises EUR10M Series A backed by 360 Capital and Amadeus Capital Partners
- Deal SpotlightKissht raises EUR91.5M Series C+ backed by 360 One and Axis Mutual Fund
- Deal AnalysisDialybrid secures €15M Series A led by XGEN Venture in healthcare
Explore the full dataset
Brouky tracks 37,000+ investors and 122,000+ investments across 134,000+ startups. Search by country, stage, and sector.